These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36493396)

  • 1. Provider and patient knowledge gaps on biosimilars: insights from surveys.
    Gibofsky A; Evans C; Strand V
    Am J Manag Care; 2022 Nov; 28(12 Suppl):S227-S233. PubMed ID: 36493396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Stakeholder Learnings Regarding Biosimilars: Part I-Improving Biosimilar Understanding and Adoption.
    Barbier L; Simoens S; Vulto AG; Huys I
    BioDrugs; 2020 Dec; 34(6):783-796. PubMed ID: 33141421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Stakeholder Learnings Regarding Biosimilars: Part II-Improving Biosimilar Use in Clinical Practice.
    Barbier L; Simoens S; Vulto AG; Huys I
    BioDrugs; 2020 Dec; 34(6):797-808. PubMed ID: 33063267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge, perceptions, attitude, barriers and facilitators of biosimilars use across specialty physicians and hospital pharmacists: A national survey.
    Marín-Jiménez I; Carrascosa JM; Guigini MA; Monte-Boquet E
    Farm Hosp; 2021 Jul; 45(5):240-246. PubMed ID: 34806583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Regulatory Concerns of Biosimilars: A Review of Literature.
    Halimi V; Daci A; Ancevska Netkovska K; Suturkova L; Babar ZU; Grozdanova A
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32796549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians.
    Cohen H; Beydoun D; Chien D; Lessor T; McCabe D; Muenzberg M; Popovian R; Uy J
    Adv Ther; 2017 Jan; 33(12):2160-2172. PubMed ID: 27798772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding US Physician and Pharmacist Attitudes Toward Biosimilar Products: A Qualitative Study.
    Rupert DJ; Jordan AM; Ziemian MA; Brown RM; Fleming NS; Lefebvre RC
    BioDrugs; 2022 Sep; 36(5):645-655. PubMed ID: 35962911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing awareness and attitudes of healthcare professionals on the use of biosimilar medicines: A survey of physicians and pharmacists in Ireland.
    O'Callaghan J; Bermingham M; Leonard M; Hallinan F; Morris JM; Moore U; Griffin BT
    Regul Toxicol Pharmacol; 2017 Aug; 88():252-261. PubMed ID: 28666961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians.
    Barbier L; Vandenplas Y; Simoens S; Declerck P; Vulto AG; Huys I
    J Pharm Policy Pract; 2021 Jun; 14(1):53. PubMed ID: 34158128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacists' Perspectives of Biosimilars: A Systematic Review.
    Mohd Sani N; Aziz Z; Panickar R; Kamarulzaman A
    BioDrugs; 2022 Jul; 36(4):489-508. PubMed ID: 35776294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician attitudes about non-medical switching to biosimilars: results from an online physician survey in the United States.
    Teeple A; Ellis LA; Huff L; Reynolds C; Ginsburg S; Howard L; Walls D; Curtis JR
    Curr Med Res Opin; 2019 Apr; 35(4):611-617. PubMed ID: 30712393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Affecting Health Care Provider Knowledge and Acceptance of Biosimilar Medicines: A Systematic Review.
    Leonard E; Wascovich M; Oskouei S; Gurz P; Carpenter D
    J Manag Care Spec Pharm; 2019 Jan; 25(1):102-112. PubMed ID: 30589628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The growing role of biologics and biosimilars in the United States: Perspectives from the APhA Biologics and Biosimilars Stakeholder Conference.
    Crespi-Lofton J; Skelton JB
    J Am Pharm Assoc (2003); 2017; 57(5):e15-e27. PubMed ID: 28689708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician Understanding and Willingness to Prescribe Biosimilars: Findings from a US National Survey.
    Kolbe AR; Kearsley A; Merchant L; Temkin E; Patel A; Xu J; Jessup A
    BioDrugs; 2021 May; 35(3):363-372. PubMed ID: 33826078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives of Hospital Pharmacists Towards Biosimilar Medicines: A Survey of Polish Pharmacy Practice in General Hospitals.
    Pawłowska I; Pawłowski L; Krzyżaniak N; Kocić I
    BioDrugs; 2019 Apr; 33(2):183-191. PubMed ID: 30830647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunities and challenges in biosimilar uptake in oncology.
    Dolan C
    Am J Manag Care; 2018 Jun; 24(11 Suppl):S237-S243. PubMed ID: 29957909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable.
    Afzali A; Furtner D; Melsheimer R; Molloy PJ
    Adv Ther; 2021 May; 38(5):2077-2093. PubMed ID: 33745111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embracing Change: An International Survey Study on the Beliefs and Attitudes of Pediatric Rheumatologists Towards Biosimilars.
    Demirkan FG; Sönmez HE; Lamot L; Akgün Ö; Sözeri B; Ayaz NA;
    BioDrugs; 2022 May; 36(3):421-430. PubMed ID: 35380389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of pharmacists' views on biosimilar naming conventions.
    Fernandez-Lopez S; Kazzaz D; Bashir M; McLaughlin T
    J Manag Care Spec Pharm; 2015 Mar; 21(3):188-95. PubMed ID: 25726028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of pharmacists' knowledge and views of biosimilars in Quebec and France.
    Adé A; Bourdon O; Bussières JF
    Ann Pharm Fr; 2017 Jul; 75(4):267-275. PubMed ID: 28237527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.